1. A comparison of weekly versus 3-weekly cisplatin during adjuvant radiotherapy for high-risk head and neck cancer. (August 2016) Authors: Oosting, Sjoukje F.; Chen, Tom W.W.; Huang, Shao H.; Wang, Lisa; Waldron, John; Gilbert, Ralph; Goldstein, David; Halmos, Gyorgy B.; Witjes, Max J.H.; Gietema, Jourik A.; O'Sullivan, Brian; Langendijk, Johannes A.; Siu, Lillian L.; Hansen, Aaron R. Journal: Oral oncology Issue: Volume 59(2016:Aug.) Page Start: 43 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A comparison of weekly versus 3-weekly cisplatin during adjuvant radiotherapy for high-risk head and neck cancer. (August 2016) Authors: Oosting, Sjoukje F.; Chen, Tom W.W.; Huang, Shao H.; Wang, Lisa; Waldron, John; Gilbert, Ralph; Goldstein, David; Halmos, Gyorgy B.; Witjes, Max J.H.; Gietema, Jourik A.; O'Sullivan, Brian; Langendijk, Johannes A.; Siu, Lillian L.; Hansen, Aaron R. Journal: Oral oncology Issue: Volume 59(2016:Aug.) Page Start: 43 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A cost‐effectiveness analysis of human papillomavirus vaccination of boys for the prevention of oropharyngeal cancer. Issue 11 (13th April 2015) Authors: Graham, Donna M.; Isaranuwatchai, Wanrudee; Habbous, Steven; de Oliveira, Claire; Liu, Geoffrey; Siu, Lillian L.; Hoch, Jeffrey S. Journal: Cancer Issue: Volume 121:Issue 11(2015) Page Start: 1785 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A multicenter, phase 3, randomized trial of concurrent chemoradiotherapy plus adjuvant chemotherapy versus radiotherapy alone in patients with regionally advanced nasopharyngeal carcinoma: 10‐year outcomes for efficacy and toxicity. Issue 21 (29th June 2017) Authors: Lee, Anne W. M.; Tung, Stewart Y.; Ng, Wai Tong; Lee, Victor; Ngan, Roger K. C.; Choi, Horace C. W.; Chan, Lucy L. K.; Siu, Lillian L.; Ng, Alice W. Y.; Leung, To Wai; Yiu, Harry H. Y.; O'Sullivan, Brian; Chappell, Rick Journal: Cancer Issue: Volume 123:Issue 21(2017) Page Start: 4147 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A Phase I Study of Dinaciclib in Combination With MK‐2206 in Patients With Advanced Pancreatic Cancer. Issue 6 (1st August 2020) Authors: Murphy, Adrian G.; Zahurak, Marianna; Shah, Mirat; Weekes, Colin D.; Hansen, Aaron; Siu, Lillian L.; Spreafico, Anna; LoConte, Noelle; Anders, Nicole M.; Miles, Tearra; Rudek, Michelle A.; Doyle, L. Austin; Nelkin, Barry; Maitra, Anirban; Azad, Nilofer S. Journal: Clinical and translational science Issue: Volume 13:Issue 6(2020) Page Start: 1178 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. A phase I trial of two sequence-specific schedules of decitabine and vorinostat in patients with acute myeloid leukemia. Issue 10 (3rd October 2015) Authors: How, Jonathan; Minden, Mark D.; Brian, Leber; Chen, Eric X.; Brandwein, Joseph; Schuh, Andre C.; Schimmer, Aaron D.; Gupta, Vikas; Webster, Sheila; Degelder, Tammy; Haines, Patricia; Stayner, Lee-Anne; McGill, Shauna; Wang, Lisa; Piekarz, Richard; Wong, Tracy; Siu, Lillian L.; Espinoza-Delgado, I... Journal: Leukemia & lymphoma Issue: Volume 56:Issue 10(2015:Oct.) Page Start: 2793 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. A risk stratification model for toxicities in phase 1 immunotherapy trials. (November 2022) Authors: Hernando-Calvo, Alberto; Salawu, Abdulazeez; Chen, Rachel Y.; Araujo, Daniel V.; Oliva, Marc; Liu, Zhihui Amy; Siu, Lillian L. Journal: European journal of cancer Issue: Volume 175(2022) Page Start: 11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. A six-weekly dosing schedule for pembrolizumab in patients with cancer based on evaluation using modelling and simulation. (May 2020) Authors: Lala, Mallika; Li, Tommy Ruosi; de Alwis, Dinesh P.; Sinha, Vikram; Mayawala, Kapil; Yamamoto, Noboru; Siu, Lillian L.; Chartash, Elliot; Aboshady, Hesham; Jain, Lokesh Journal: European journal of cancer Issue: Volume 131(2020) Page Start: 68 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. All is not lost: learning from 9p21 loss in cancer. Issue 5 (May 2022) Authors: Spiliopoulou, Pavlina; Yang, S.Y. Cindy; Bruce, Jeff P.; Wang, Ben X.; Berman, Hal K.; Pugh, Trevor J.; Siu, Lillian L. Journal: Trends in immunology Issue: Volume 43:Issue 5(2022) Page Start: 379 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. An interim report on the investigator-initiated phase 2 study of pembrolizumab immunological response evaluation (INSPIRE). Issue 1 (13th March 2019) Authors: Clouthier, Derek L.; Lien, Scott C.; Yang, S. Y. Cindy; Nguyen, Linh T.; Manem, Venkata S. K.; Gray, Diana; Ryczko, Michael; Razak, Albiruni R. A.; Lewin, Jeremy; Lheureux, Stephanie; Colombo, Ilaria; Bedard, Philippe L.; Cescon, David; Spreafico, Anna; Butler, Marcus O.; Hansen, Aaron R.; Jang, ... Journal: Journal for immunotherapy of cancer Issue: Volume 7:Issue 1(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗